These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1158 related articles for article (PubMed ID: 1531321)

  • 21. T cell regulation of human B cell proliferation and differentiation. Regulatory influences of CD45R+ and CD45R- T4 cell subsets.
    Hirohata S; Lipsky PE
    J Immunol; 1989 Apr; 142(8):2597-607. PubMed ID: 2564858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
    J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concomitant administration of hapten and IL-2-toxin (DAB486-IL-2) results in specific deletion of antigen-activated T cell clones.
    Bastos MG; Pankewycz O; Rubin-Kelley VE; Murphy JR; Strom TB
    J Immunol; 1990 Dec; 145(11):3535-9. PubMed ID: 2147194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory function for murine intraepithelial lymphocytes. Two subsets of CD3+, T cell receptor-1+ intraepithelial lymphocyte T cells abrogate oral tolerance.
    Fujihashi K; Taguchi T; McGhee JR; Eldridge JH; Bruce MG; Green DR; Singh B; Kiyono H
    J Immunol; 1990 Oct; 145(7):2010-9. PubMed ID: 1975820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct subsets of accessory cells activate Thy-1+ triple negative (CD3-, CD4-, CD8-) cells and Th-1 delayed-type hypersensitivity effector T cells.
    Matsushima GK; Stohlman SA
    J Immunol; 1991 May; 146(10):3322-31. PubMed ID: 1673982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimal growth requirements of mature T lymphocytes: interleukin (IL)-1 and IL-6 increase growth rate but not plating efficiency of CD4 cells stimulated with anti-CD3 and IL-2.
    Soldaini E; MacDonald HR; Nabholz M
    Eur J Immunol; 1992 Jul; 22(7):1707-11. PubMed ID: 1352498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
    Smyth MJ; Norihisa Y; Ortaldo JR
    J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of therapeutic T lymphocytes from tumor-bearing mice by in vitro sensitization. Culture requirements and characterization of immunologic specificity.
    Chou T; Chang AE; Shu SY
    J Immunol; 1988 Apr; 140(7):2453-61. PubMed ID: 2450925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW; Liao CH; Ying C; Chang CJ; Lin CM
    Clin Immunol; 2006 Apr; 119(1):21-31. PubMed ID: 16406844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 co-stimulation.
    Seeley BM; Barthel SW; To WC; Kjaergaard J; Shu S; Plautz GE
    Otolaryngol Head Neck Surg; 2001 Apr; 124(4):436-41. PubMed ID: 11283503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS; Hargrove ME; Ting CC
    Cancer Res; 1989 Sep; 49(17):4770-4. PubMed ID: 2527087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intact antigen receptor-mediated generation of inositol phosphates and increased intracellular calcium in CD4 CD8 T lymphocytes from MRL lpr mice.
    Budd RC; Winslow G; Inokuchi S; Imboden JB
    J Immunol; 1990 Nov; 145(9):2862-72. PubMed ID: 1976707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes.
    Chin CS; Miller CH; Graham L; Parviz M; Zacur S; Patel B; Duong A; Bear HD
    Int Immunol; 2004 Sep; 16(9):1283-94. PubMed ID: 15262898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic efficacy of Th1 and Th2 L-selectin--CD4+ tumor-reactive T cells.
    To WC; Seeley BM; Barthel SW; Shu S
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1648-54. PubMed ID: 11037819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis.
    Zipris D; Lazarus AH; Crow AR; Hadzija M; Delovitch TL
    J Immunol; 1991 Jun; 146(11):3763-71. PubMed ID: 1827815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.
    Leite-de-Moraes MC; Herbelin A; Machavoine F; Vicari A; Gombert JM; Papiernik M; Dy M
    J Immunol; 1995 Nov; 155(10):4544-50. PubMed ID: 7594451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.
    Flamand V; Abramowicz D; Goldman M; Biernaux C; Huez G; Urbain J; Moser M; Leo O
    J Immunol; 1990 Apr; 144(8):2875-82. PubMed ID: 1969874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.